A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
Laboratory Developed Tests (LDT) have been attracting a lot of attention in recent years, but they are not a new or recent phenomenon. Historically, these tests were called home-brew tests or in-house tests. Also historically, these tests were low-volume, simple and well characterized tests for low-risk diagnostic applications. Today, high-risk, complex tests have been developed as LDTs, and are being used to provide clinical results to physicians and their patients.

Market Analysis and Insights: Global Laboratory Developed Tests (LDT) Market
The global Laboratory Developed Tests (LDT) market size is projected to reach US$ 17450 million by 2027, from US$ 10570 million in 2020, at a CAGR of 7.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Laboratory Developed Tests (LDT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Laboratory Developed Tests (LDT) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Laboratory Developed Tests (LDT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Laboratory Developed Tests (LDT) market.

Global Laboratory Developed Tests (LDT) Scope and Market Size
Laboratory Developed Tests (LDT) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Laboratory Developed Tests (LDT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Clinical Biochemistry
Hematology
Immunology
Molecular Diagnostics
Others

Segment by Application
Hospitals Laboratory
Clinical Research Organizations
Academic Institutes
Specialty Diagnostic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Quest Diagnostics
Thermo Fisher
Waters Corporation
Roche
IlluminA
Qiagen
23andMe
Eurofins
Guardant Health
BiOthersanostics
Adaptive Biotechnologies
Rosetta Genomics
Biodesix
Helix